BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Topic

Serum Institute of India

India's Serum Institute 'to invest in UK'

India's Serum Institute 'to invest in UK'

Published 04 May, 2021 10:03am
  • The Serum Institute of India (SII) is the world's largest vaccine maker by volume, and has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot.
India AstraZeneca shot delay could be 'catastrophic' for Africa

India AstraZeneca shot delay could be 'catastrophic' for Africa

Published 01 Apr, 2021 05:47pm
  • India decided to delay big exports of the shots made in its territory by the Serum Institute of India (SII) to make sure it could meet local demand, two sources told Reuters last week.
  • The African Union had planned to vaccinate 20%-30% of the continent's population by the end of the year he said. "If the vaccines are delayed we are unlikely to meet our target," he added.
Indonesia sees vaccination slowdown as India delays shipments

Indonesia sees vaccination slowdown as India delays shipments

Published 27 Mar, 2021 08:42pm
  • India's move will affect supplies to the GAVI/WHO-backed global COVAX vaccine-sharing facility, through which 64 lower-income countries including Indonesia are supposed to get doses from SII. "This definitely will affect (the vaccination process) because in April we only have around 7 million doses from Sinovac," Budi said.
Serum Institute delays expected launch of Novavax vaccine in India

Serum Institute delays expected launch of Novavax vaccine in India

Published 27 Mar, 2021 06:01pm
  • Adar Poonawalla, the chief executive of Serum, said in January that the vaccine, named Corovax, was expected to be launched by June.
  • "It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%," tweeted Poonawalla, whose Serum Institute is the world's largest manufacturer of vaccines.
Bangladesh seeks to double vaccine purchases from Serum Institute of India

Bangladesh seeks to double vaccine purchases from Serum Institute of India

Updated 04 Mar, 2021 09:52pm
  • Bangladesh is also due to get a total of 68 million doses of vaccines from a WHO-backed alliance, with the first shipment of around 10 million doses expected by June, Mannan said.
  • "We have not ordered for any additional doses. As of now our total order is for 30 million doses," Beximco Pharmaceuticals' Chief Operating Officer Rabbur Reza told Reuters.
India to ship COVID-19 vaccines to Canada as diplomatic tension eases

India to ship COVID-19 vaccines to Canada as diplomatic tension eases

Published 15 Feb, 2021 07:15pm
  • Trudeau said the months-long protests by farmers on the outskirts of Delhi were concerning, drawing a rebuke from the Indian government which said it was an internal matter.
  • Modi also said India would do its best to supply COVID-19 vaccines sought by Canada.
Verity Pharma and India's SII apply to distribute AstraZeneca vaccine in Canada

Verity Pharma and India's SII apply to distribute AstraZeneca vaccine in Canada

Published 02 Feb, 2021 07:15pm
  • SII, the world's biggest vaccine maker, has capacity to produce roughly 2.4 million doses per day at its campus in Pune, western India.
  • Verity Pharmaceuticals is providing important support to Serum Institute of India related to its regulatory registration, importation and distribution of the vaccine in Canada, pending Health Canada approval.
Ukraine in talks with India on COVID-19 vaccine supply

Ukraine in talks with India on COVID-19 vaccine supply

Published 20 Jan, 2021 08:47pm
  • Negotiations are underway with an Indian manufacturer, Serum Institute, which can produce the American Novovax vaccine and has the ability to produce the AstraZeneca vaccine at the moment.
  • India will initially only ship the AstraZeneca vaccine, made by The Serum Institute,
India to start COVID-19 vaccine exports as soon as Wednesday

India to start COVID-19 vaccine exports as soon as Wednesday

Published 19 Jan, 2021 06:19pm
  • The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.
  • India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.
Bangladesh to begin COVID-19 vaccinations next month

Bangladesh to begin COVID-19 vaccinations next month

Published 11 Jan, 2021 09:43pm
  • The South Asian country of more than 160 million in November signed a deal with the Serum Institute of India to buy 30 million doses of the vaccine developed by British drugmaker AstraZeneca.
  • The vaccine will be first applied on the health workers and it will be monitored for the next seven days. After that, we'll begin the vaccination across the country in the first week of February.
India signs purchase order with Serum for AstraZeneca vaccine

India signs purchase order with Serum for AstraZeneca vaccine

Published 11 Jan, 2021 06:32pm
  • Local television channel CNBC-TV 18 said the order was for 11 million doses and the government would buy the shots at 200 rupees ($2.72) per dose.
  • The government has also signed a purchase agreement with Indian firm Bharat Biotech for its COVID-19 vaccine.
Indian vaccine makers end spat, pledge 'smooth rollout' of COVID-19 shots

Indian vaccine makers end spat, pledge 'smooth rollout' of COVID-19 shots

Published 05 Jan, 2021 07:43pm
  • Both companies respect the great work being carried out by each other and put behind us the miscommunication and misunderstanding caused during the past week.
  • India's drugs regulator on Sunday approved for emergency use a vaccine developed by AstraZeneca and Oxford University.
Loading...